These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34247265)

  • 21. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
    Glover EM; Davis M
    Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats.
    Gao JL; Tu SA; Liu J; Zhang JM; Huang Y; Han M; Liang JH
    BMC Complement Altern Med; 2014 Aug; 14():308. PubMed ID: 25134609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of buprenorphine on fentanyl withdrawal in rats.
    Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
    Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
    Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
    Walker EA; Young AM
    Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
    de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
    Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of buprenorphine on motility in morphine post-dependent rats.
    Bartoletti M; Gaiardi M; Gubellini C
    Pharmacol Res; 1999 Oct; 40(4):327-32. PubMed ID: 10527644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
    Wu P; Shi HS; Luo YX; Zhang RX; Li JL; Shi J; Lu L; Zhu WL
    Psychopharmacology (Berl); 2014 Dec; 231(24):4659-68. PubMed ID: 24825609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasounds during morphine withdrawal in rats.
    Vivian JA; Miczek KA
    Psychopharmacology (Berl); 1991; 104(2):187-93. PubMed ID: 1876663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
    Singh P; Sharma B; Gupta S; Sharma BM
    Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voluntary Running-Wheel Activity, Arterial Blood Gases, and Thermal Antinociception in Rats after 3 Buprenorphine Formulations.
    Johnson RA
    J Am Assoc Lab Anim Sci; 2016; 55(3):306-11. PubMed ID: 27177564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.
    Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK
    J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol administration increases anxiety-like behavior following chronic escalating morphine administration in hormone-replaced ovariectomized female rats.
    Ellis MN; Wright MD; Dennis TS
    Pharmacol Biochem Behav; 2023 Jun; 227-228():173582. PubMed ID: 37302663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
    Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
    Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.